Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

9.705 -0.345 (-3.43%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,370
Open 9.860
Bid (Size) 9.250 (10)
Ask (Size) 9.850 (1)
Prev. Close 10.05
Today's Range 9.255 - 10.27
52wk Range 4.930 - 221.94
Shares Outstanding 574,580
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Scientists Stunned Upon Discovering Glioblastoma Erodes Skull Tissue
Via Investor Brand Network
Scorpion Venom Shows Promise in Brain Tumor Treatment
Via Investor Brand Network

Performance

YTD
-86.2%
-86.2%
1 Month
+29.1%
+29.1%
3 Month
-7.6%
-7.6%
6 Month
-36.8%
-36.8%
1 Year
-86.3%
-86.3%

More News

Read More
Rogue Rings of DNA Expose Brain Tumor Secrets
Via Investor Brand Network
New Research Suggests Dietary Change Could Improve Glioblastoma Treatment Outcomes
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NCI Halts Funding for Consortium Conducting Trials on Childhood Brain Cancers
Via Investor Brand Network
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Via ACCESS Newswire
Study Finds Link Between Head Injuries and Elevated Brain Cancer Risk
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Drug Development and Market Potential on BioMedWire Podcast
Via Investor Brand Network
Blocking Glioblastoma-Triggered Brain Damage Could Slow the Aggressive Tumor’s Growth
Via Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial
Via Investor Brand Network
CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Via ACCESS Newswire
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Webull Financial Biotech/MedTech Webinar Series
Via Investor Brand Network
What Women Need to Know About Benign Brain Tumors
Via Investor Brand Network
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Via ACCESS Newswire
Study Reveals Potential Way to Treat Pediatric Gliomas
Via Investor Brand Network
Study Identifies Genetic Marker Helpful in Guiding Brain Tumor Treatment
Via Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Virtual Investor Summer Spotlight Conference
Via Investor Brand Network
Unexpected Finding Potentially Opens the Door to Universal Vaccines Against Cancer
Via Investor Brand Network
CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
Via ACCESS Newswire
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
Via ACCESS Newswire
New Machine Learning Model Predicts Cancer Severity, Aids Treatment Planning
Via Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22
Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 9.705
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 10/10/25 03:59 PM ET
What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 5.58M
How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
CNS Pharmaceuticals, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.